Literature DB >> 32271427

Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.

J-L Zhou1, L Zou, T Zhu.   

Abstract

OBJECTIVE: In recent years, studies have found that abnormally expressed long non-coding RNA (lncRNA) is closely associated with the progression of breast cancer (BCa). Some lncRNAs have been identified to be involved in the regulation of BCa cell invasion and metastasis. In this research, LINC00665 was found to be abnormally expressed in BCa tissues and cells, and its regulatory effects on invasion and metastasis of BCa were explored. The aim of this study was to investigate the expression characteristics of LINC00665 in BCa, and its regulatory role in BCa progression. PATIENTS AND METHODS: LINC00665 expressions in BCa tissue samples and normal ones were collected from GEPIA database. The expression of LINC00665 in BCa tissues and cell lines was further confirmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). After knockdown of LINC00665 expression in BCa cells by transfection of small interfering RNA, cell migration and invasion abilities were examined by cell wound healing and transwell assay. Expressions of epithelial-mesenchymal transition (EMT)-related markers in BCa cells were examined using qRT-PCR and Western blot.
RESULTS: LINC00665 was highly expressed in BCa tissues and cell lines, and the high expression of LINC00665 could be used to predict a poor prognosis of BCa patients. In addition, the results of in vitro cell experiments showed that the migration and invasion ability of BCa cells were remarkably attenuated after downregulation of LINC00665. At the same time, qRT-PCR and Western blot results revealed that downregulation of LINC00665 was able to inhibit the expressions of EMT-related genes in BCa cells.
CONCLUSIONS: LINC00665 is highly expressed in BCa tissues and cell lines, which could predict poor prognosis of BCa patients. In addition, LINC00665 may promote the malignant metastasis of BCa cells by affecting the EMT process.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32271427     DOI: 10.26355/eurrev_202003_20674

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

Review 1.  The Biological and Molecular Function of LINC00665 in Human Cancers.

Authors:  Cheng Zhang; Shu-Ning Xu; Ke Li; Jing-Hong Chen; Qun Li; Ying Liu
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 2.  LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.

Authors:  Chenming Zhong; Zijun Xie; Jinze Shen; Yunhua Jia; Shiwei Duan
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

3.  LINC00665 Facilitates the Malignant Processes of Osteosarcoma by Increasing the RAP1B Expression via Sponging miR-708 and miR-142-5p.

Authors:  Limin Wang; Xinghua Song; Lijun Yu; Bing Liu; Jinfeng Ma; Weihua Yang
Journal:  Anal Cell Pathol (Amst)       Date:  2021-07-07       Impact factor: 2.916

4.  LINC00665 Stimulates Breast Cancer Progression via Regulating miR-551b-5p.

Authors:  Liqiang Qi; Bo Sun; Beibei Yang; Su Lu
Journal:  Cancer Manag Res       Date:  2021-02-05       Impact factor: 3.989

5.  Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients.

Authors:  Huijuan Dai; Xiaonan Sheng; Rui Sha; Jing Peng; Fan Yang; Liheng Zhou; Yanping Lin; Yaqian Xu; Shan Zhang; Wenjin Yin; Jinsong Lu
Journal:  Front Oncol       Date:  2021-03-02       Impact factor: 6.244

Review 6.  The Impact of Non-coding RNAs in the Epithelial to Mesenchymal Transition.

Authors:  Bashdar Mahmud Hussen; Hamed Shoorei; Mahdi Mohaqiq; Marcel E Dinger; Hazha Jamal Hidayat; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Mol Biosci       Date:  2021-03-26

7.  LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).

Authors:  Wen Cao; Xiaojing Liu; Weijia Su; Hao Liang; Huiru Tang; Weiliang Zhang; Shuhong Huang; Ningning Dang; Aiguo Qiao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 8.  The Emerging Roles of LINC00665 in Human Cancers.

Authors:  Jing Zhu; Yirao Zhang; Xuyu Chen; Yibo Bian; Juan Li; Keming Wang
Journal:  Front Cell Dev Biol       Date:  2022-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.